- Home
- / Genomic Vision
Genomic Vision
Total Funding
$2.4 M
Revenue
€1 M
FY, 2022
Genomic Vision Summary
Company Summary
- Overview
- Genomic Vision is a biotechnology company developing genetic tests and research tools for the life sciences sector. It focuses on DNA analysis and genetic testing in the fields of cancer, inherited disorders, and pharmacogenomics.
- Type
- Private
- Status
- Active
- Founded
- 2005
- HQ
- Paris, FR | view all locations
- Cybersecurity rating
Table of Contents
Key People
Eric Edery, Vice-President
Lionel Seltz, CFO
Mohammad Afshar, Supervisory Board Member
LocationsView all
1 location detected
Paris, IDF HQ
France
47 Rue de Monceau
Genomic Vision Financials
Summary Financials
- Revenue (H1, 2023)
- €593.0K
- Gross profit (H1, 2023)
- €906.0K
- Net income (H1, 2023)
- (€6.4M)
- Cash (H1, 2023)
- €14.0K
- EBIT (H1, 2023)
- (€4.4M)